Press release
Cancer Immunotherapy Market Growth Insights Forecast 2025 | Checkpoint Inhibitors, CAR-T Cell Therapy & Precision Treatments
Cancer Immunotherapy market
Download your FREE sample report: https://www.datamintelligence.com/download-sample/cancer-immunotherapy-market?jd
Emerging opportunities in the field are marked by the expansion of combination therapies (e.g., immunotherapy plus chemotherapy or targeted agents), the move towards personalized and precision medicine leveraging biomarkers and genomic profiling, and innovations in administration such as subcutaneous and oral immunotherapy formulations that improve patient convenience and adherence.
Recent Key Alliances and Acquisitions Driving the Evolution of the 2025 Cancer Immunotherapy Market Landscape
• Bristol Myers Squibb partnership with BioNTech (June 2025): BMS agreed to pay $1.5 billion upfront, with total deal value up to $11.1 billion to develop and commercialize BioNTech's BNT327 bispecific antibody for multiple solid tumors, including lung cancer. This collaboration combines immune checkpoint blockade with anti-angiogenesis to enhance anticancer efficacy.
• Pierre Fabre acquisition of rights to mutant-specific EGFR inhibitors (June 2025): Pierre Fabre acquired worldwide rights to PFL-721 and PFL-241, enhancing its precision oncology portfolio targeting EGFR mutations in non-small cell lung cancer, among others.
• OS Therapies acquisition of Advaxis Immunotherapies assets (April 2025): OS Therapies completed the acquisition of listeria-based cancer immunotherapy assets from Advaxis, consolidating intellectual property and expanding its pipeline with multiple cancer immunotherapy candidates targeting over 30 cancer types, including their lead asset, OST-HER2, targeting lung metastatic osteosarcoma.
Innovative Technologies Revolutionizing the Cancer Immunotherapy Market Outlook in 2025
• Monoclonal Antibodies and Immune Checkpoint Inhibitors remain the dominant class, accounting for over 65% market share. Agents like pembrolizumab, nivolumab, and atezolizumab target PD-1, PD-L1, and CTLA-4 checkpoints, enhancing T-cell-mediated tumor destruction. Newer checkpoint targets (LAG-3, TIGIT) are emerging in clinical use or trials.
• Combination Therapies: Combining immunotherapy with chemotherapy, targeted agents, or radiation has become standard in many cancers. Combination checkpoint blockade (e.g., nivolumab plus ipilimumab) is also used to improve response durability and overcome resistance.
• Cell-Based Therapies: CAR-T cell therapies are expanding beyond hematologic malignancies into solid tumors. Technological advances in improving CAR design, manufacturing scalability, and safety profiles (like off-the-shelf allogeneic CAR-T) are driving growth.
• Cancer Vaccines and Oncolytic Viruses: Personalized neoantigen vaccines and virus-based therapies that stimulate antitumor immunity are in advanced trials, promising personalized immunotherapies with fewer side effects.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cancer-immunotherapy-market?jd
Regional Growth Catalysts Steering the Cancer Immunotherapy Market Dynamics in 2025
North America leads the global cancer immunotherapy market, holding over 45% of the total market share. This dominance is due to advanced healthcare infrastructure, significant R&D investments, favorable regulatory environments, and early adoption of novel immunotherapies such as checkpoint inhibitors, CAR-T cell therapies, and monoclonal antibodies.
Europe is the second-largest market, characterized by established healthcare systems, active clinical research, and growing governmental support for faster approval of immunotherapies. Countries like Germany, the UK, and France are key contributors, driven by cross-border collaborations, rising cancer prevalence, and expanded reimbursement for innovative treatments.
Asia Pacific is the fastest-growing regional market, forecast to achieve a CAGR of up to 18.22% through 2030. Growth drivers include a rapidly increasing cancer patient population, improving healthcare infrastructure, rising healthcare spending, greater participation in immunotherapy clinical trials, and a surge in government and private-sector investment in oncology.
Request for 2 Days FREE Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg?jd
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a leading market research and consulting firm offering end-to-end business solutions from research to strategy consulting. Leveraging industry trends, insights, and extensive data across more than 6,300 reports in over 40 sectors, DataM Intelligence supports over 200 clients across 50+ countries. Our comprehensive research methodologies empower organizations with actionable intelligence to drive growth and innovation.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Immunotherapy Market Growth Insights Forecast 2025 | Checkpoint Inhibitors, CAR-T Cell Therapy & Precision Treatments here
News-ID: 4131856 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
North America Vaginal Health Probiotic Supplements Market to Double, Reaching $2 …
The North America vaginal health probiotic supplements market reached US$111.93 million in 2024 and is expected to reach US$225.99 million by 2032, growing at a CAGR of 9.3% during the forecast period 2025-2032.The market is growing rapidly, fueled by rising awareness of women's intimate health and the increasing prevalence of vulvovaginal discomfort. A US survey of 913 women found that 79.1% were diagnosed with genitourinary syndrome of menopause (GSM), with…
United States Silicon Drift Detectors Market Insights 2025: High-Resolution Imag …
The Global Silicon Drift Detectors Market is predicted to reach at a CAGR of 5.1% during the forecast period 2024-2031.
Silicon Drift Detectors (SDDs) are advanced semiconductor-based radiation detectors that utilize a unique lateral charge drift mechanism to achieve high energy resolution and fast response times. They are widely employed in applications requiring precise X-ray spectroscopy, such as medical imaging, industrial inspection, and scientific research. SDDs offer improved performance over traditional…
United States Data Lakes Market to Grow at 20.6% CAGR Through 2031, Driven by AI …
Global Data Lakes Market is estimated to grow at a CAGR Of 20.6% during the forecast period 2024-2031.
The data lakes market encompasses platforms that enable organizations to store vast amounts of structured and unstructured data in its raw form. These systems facilitate advanced analytics, machine learning, and real-time data processing. By consolidating diverse data sources, data lakes support scalable and cost-effective data management solutions.
Their flexibility and integration capabilities make them…
United States & Japan Semiconductor Developments: Investments, Research, and Sup …
The Global Semiconductors Market reached US$ 640.6 billion in 2022 and is expected to reach US$ 1,132.8 billion by 2031, growing with a CAGR of 7.5% during the forecast period 2024-2031. The Global Semiconductors Market is a vital and rapidly evolving industry that plays a fundamental role in various sectors of the global economy.
The semiconductor market encompasses the design, manufacturing, and sale of semiconductor devices, which are essential components…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
